Tonghua Dongbao Pharmaceutical Co., Ltd. Stock: price and insider trades · China
通化东宝
No insider purchase over the last 90 days. The latest, by 王君业, was filed 13 Nov 2024.
Tonghua Dongbao Pharmaceutical Co., Ltd.: what insiders have been doing
Tonghua Dongbao Pharmaceutical Co., Ltd., classified in the Health Care sector, is a listed company based in People's Republic of China. Its insiders report their share dealings to SSE / SZSE (CSRC). Tonghua Dongbao Pharmaceutical Co., Ltd. has had no insider filing for more than a year; the last one goes back to 13 November 2024.
Our records for Tonghua Dongbao Pharmaceutical Co., Ltd. go back to 2024, with 2 purchases and no sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Key facts
Headquarters: People's Republic of China
Source: Wikidata (CC0).
Since the insiders bought
- +5.5%Entry CN¥8.73 · Close at T+365 CN¥9.21
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of medications, particularly for diabetes treatment.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
